Boothbay Fund Management’s ResMed RMD Stock Holding History

Boothbay Fund Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-15,000	Closed	-$2.87M	–	1884
2024 Q2	$2.87M	Buy	+15,000	New	+$3.04M	0.07%	385

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Boothbay Fund Management's RMD Position: Q1 2024 in Review

Boothbay Fund Management sold out of ResMed (RMD) in Q1 2024, closing a stake of 1,444 shares — an estimated $248K sold.

Boothbay Fund Management first reported a position in RMD in Q1 2021 and held it in 11 quarters. The position peaked at $4.07M in Q1 2021. 718 funds tracked by Wall St. Rank hold RMD as of Q1 2024.

Boothbay Fund Management reported no remaining ResMed position as of Q1 2024 after selling out during the quarter.
Boothbay Fund Management sold 1,444 ResMed shares in Q1 2024, an estimated $248K.
Boothbay Fund Management first reported a position in ResMed in Q1 2021 and held it in 11 quarters.
Boothbay Fund Management's ResMed position peaked at $4.07M in Q1 2021.
718 funds tracked by Wall St. Rank held ResMed as of Q1 2024.

Based on Boothbay Fund Management's 13F filing for Q1 2024, filed 15 May 2024.